FOOD AND DRUG ADMINISTRATION

Amendments

Agriculture, rural development, FDA, and related agencies programs: making appropriations (H.R. 2112), S6516 [13OC], S6578, S6587, S6590, S6606, S6607, S6609, S6610, S6611 [17OC], S6633, S6634, S6636, S6648, S6649, S6650, S6651, S6674, S6675, S6676, S6677, S6678, S6679, S6680, S6681, S6684, S6685, S6686, S6687, S6688, S6689 [18OC], S6729, S6730, S6731, S6733, S6734, S6735, S6736, S6738, S6742, S6746, S6751, S6752, S6754, S6758, S6770, S6771, S6772, S6773, S6774, S6775, S6782, S6783, S6784, S6785, S6786 [19OC], S6806, S6807, S6808, S6809, S6841, S6849, S6850, S6882, S6883, S6887, S6888 [20OC], S6924 [31OC], S6933, S6979, S7009 [1NO], H4076, H4077 [13JN], H4152, H4164, H4165, H4166, H4168, H4169, H4170, H4171, H4174, H4175, H4176, H4179, H4180, H4181, H4188 [14JN], H4202, H4204, H4205, H4207, H4208, H4210, H4213, H4215, H4217, H4219, H4222, H4240, H4241, H4242, H4245, H4246, H4253, H4256, H4257, H4259, H4263, H4267, H4268, H4269, H4270, H4271, H4272, H4274, H4279 [15JN], H4283, H4284, H4286, H4288, H4289, H4290, H4292, H4293, H4295, H4296 [16JN]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), S1265 [4MR], S1332 [7MR], S1413 [8MR], S1511 [9MR], H776, H777, H778, H779, H780, H781, H782, H783, H784, H785, H786, H787, H788, H789, H790, H791, H792, H793, H794, H795, H796 [14FE], H830, H844, H846, H849, H854, H855, H873, H875, H878, H881, H882, H886, H888, H889, H890, H893, H895, H897, H900, H901, H902, H903, H904, H908, H910, H924, H925, H926, H927, H928, H929, H930, H931, H933, H934, H935 [15FE], H968, H970, H976, H981, H982, H984, H986, H987, H988, H989, H990, H992, H999, H1001, H1002, H1003, H1007, H1014, H1016, H1020, H1023, H1024, H1025, H1028, H1031, H1032, H1033, H1036, H1041, H1045, H1051, H1055, H1056, H1057, H1060, H1063, H1064, H1067, H1071 [16FE], H1091, H1094, H1095, H1096, H1102, H1103, H1106, H1111, H1114, H1115, H1121, H1125, H1131, H1144, H1145, H1149, H1155, H1182, H1183, H1184, H1185, H1186 [17FE], H1202, H1213, H1215, H1217, H1220, H1221, H1222, H1223, H1224, H1226, H1231, H1243, H1245, H1246, H1247, H1249, H1257, H1258, H1261, H1262, H1265, H1268, H1269, H1271, H1272, H1273, H1275, H1277, H1279, H1280, H1281, H1282, H1284, H1285, H1286, H1287, H1288, H1289, H1290, H1291, H1308, H1310, H1311, H1312, H1313, H1314, H1315, H1316, H1317, H1318, H1319, H1320, H1322, H1323, H1324, H1325, H1327, H1328, H1342, H1345, H1346, H1349 [18FE]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), consideration (H. Res. 92), H814 [15FE]

Appointments

Conferees: H.R. 2112, agriculture, rural development, FDA, and related agencies programs appropriations, S7113 [3NO], H7289 [3NO]

Articles and editorials

Food Day Includes Gravy, S6762 [19OC]

Vilsack—U.S. Largely Safe From European E. Coli Outbreak, H4165 [14JN]

Bills and resolutions

Agriculture, rural development, FDA, and related agencies programs: making appropriations (see H.R. 2112), H4034 [3JN]

———making appropriations (H.R. 2112), consideration (see H. Res. 300), H4074 [13JN]

———making appropriations (H.R. 2112), consideration of conference report (see H. Res. 467), H7713 [16NO]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (see H.R. 1), H722 [11FE]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), consideration (see H. Res. 92), H773 [14FE]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (see S. 1415), S4911 [26JY] (see H.R. 2659), H5579 [26JY]

Cosmetics: ensure safe use (see H.R. 2359), H4573 [24JN]

Dept. of HHS: reauthorize certain programs to protect against pandemics and attacks from chemical, biological, radiological, and nuclear weapons (see S. 1855), S7368 [10NO] (see H.R. 2405), H4580 [28JN]

Dietary supplements: improve safety by requiring manufacturers to register supplement products with the FDA and amending labeling requirements (see S. 1310), S4291 [30JN]

Diseases: establish a comprehensive interagency response to reduce lung cancer mortality in a timely manner (see S. 752), S2188 [6AP] (see H.R. 1394), H2410 [6AP]

———help prevent occurrence of cancer resulting from the use of ultraviolet tanning lamps by imposing more stringent controls on the use of such devices (see H.R. 1676), H2933 [2MY]

———improve priority review voucher incentive program for expedited review of treatments for tropical and rare pediatric diseases (see S. 606), S1826 [17MR] (see H.R. 3059), H6456 [23SE]

———reduce disparities and improve access to diagnosis and treatment of prostate cancer for underserved populations and men with a family history of prostate cancer (see S. 1190), S3773 [14JN] (see H.R. 2159), H4185 [14JN]

Drugs: improve capacity to prevent drug shortages (see S. 296), S614 [7FE] (see H.R. 2245), H4363 [21JN]

———improve safety (see H.R. 1483), H2603 [12AP] (see H.R. 3026), H6413 [22SE]

———increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (see S. 507), S1406 [8MR] (see H.R. 1925), H3302 [13MY]

———modify approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for relief of severe-only pain (see H.R. 1316), H2265 [1AP]

———provide additional quality control (see S. 1584), S5773 [20SE]

Federal Food, Drug, and Cosmetic Act: ensure accurate, intelligible information on dosage delivery devices packaged with liquid over-the-counter medications (see H.R. 338), H354 [19JA]

Fish and fishing: prevent approval of genetically-engineered fish (see S. 230), S359 [31JA] (see H.R. 521), H549 [8FE]

———require labeling of genetically-engineered fish (see S. 229), S359 [31JA] (see H.R. 520), H549 [8FE]

Folic acid: evaluate evidence on whether to add more folic acid to enriched grain products and expand folic acid fortification into cornmeal and corn-based food products to help prevent birth defects, H41 [5JA]

Food: establish and enforce a maximum somatic cell count requirement for fluid milk (see S. 458), S1120 [2MR]

Government regulation: improve humanitarian device regulation (see H.R. 3211), H6976 [14OC]

Government regulations: amend mission to establish a predictable, consistent and transparent regulatory environment (see S. 1972), S8461 [8DE] (see H.R. 3214), H6976 [14OC]

———create a pathway for premarket notification and review of laboratory-developed tests (see H.R. 3207), H6975 [14OC]

———ensure appointments to advisory committees are made to promote scientific and technical expertise while minimizing conflicts of interest (see H.R. 3206), H6975 [14OC]

———ensure public participation in the drafting and issuance of certain guidance documents (see H.R. 3204), H6975 [14OC]

———enter into agreements with certain countries regarding methods and approaches to harmonizing certain regulatory requirements on devices (see H.R. 3230), H6976 [14OC]

———expedite process for requesting de novo classification of a device (see S. 1943), S8183 [5DE] (see H.R. 3203), H6975 [14OC]

———finalize proposed rule on sunscreen product labeling (see S. 1064), S3338 [25MY]

———make clarifications relative to persons accredited to review reports and make recommendations for initial classification of devices (see H.R. 3205), H6975 [14OC]

———nullify certain regulations relative to removal of essential-use designation for epinephrine used in oral pressurized metered-dose inhalers (see S. 1752), S6872 [20OC]

———promote development of medical devices for patients with rare diseases, improve medical device approval process, and lift profit cap on humanitarian use devices (see S. 1865), S7451 [15NO]

———provide predictability, consistency, and transparency to the premarket review process (see H.R. 3209), H6976 [14OC]

———reaffirm the Safe Medical Devices Act by requiring establishment of a schedule and issuance of regulations relative to device approval process (see H.R. 3208), H6975 [14OC]

———reduce regulatory burdens that unnecessarily delay new medical devices from reaching the market (see S. 1700), S6505 [13OC]

———regulations concerning safe dietary ingredients in dietary supplements (see H.R. 3380), H7397 [4NO]

———require certain agencies to submit a cost-benefit analysis to Congress before implementing proposed regulations with significant economic impact (see H.R. 2175), H4186 [14JN]

———revise regulations applicable to the declaration of the trans fat content of a food on the label and in the labeling of the food when such content is below a certain level (see H.R. 1486), H2603 [12AP]

Health: allow manufacturers to distribute and cite scientific research on health benefits of foods and dietary supplements without affecting regulatory category of the product (see H.R. 1364), H2326 [5AP]

———ensure the FTC bears the burden of proof in false advertising cases involving dietary supplements and dietary ingredients (see H.R. 2045), H3755 [26MY]

———finalize a standard for broad-spectrum protection in sunscreen products (see H.R. 2132), H4035 [3JN]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see H.R. 2736), H5883 [1AU]

Hereditary Angioedema Awareness Day: observance (see S. Res. 286), S6185 [5OC]

Medical gases: provide for regulation (see H.R. 2227), H4326 [16JN]

Pharmaceuticals: allow fast track approval of certain orphan drugs (see H.R. 3737), H10013 [20DE]

———allow importation of prescription drugs (see S. 319), S642 [10FE]

———ensure valid generic drugs may enter the market (see S. 1882), S7612 [16NO]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 27), S122 [25JA]

Pharmacies: improve the safety of Internet pharmacies (see S. 2002), S8679 [15DE]

Product safety: enhance oversight of medical device recalls and provide for conditional clearance of certain medical devices (see S. 1995), S8602 [14DE]

Research: provide incentives for the development of qualified infectious disease products (see S. 1734), S6764 [19OC] (see H.R. 2182), H4276 [15JN]

Science: establish a nanotechnology regulatory science program (see S. 1662), S6330 [6OC]

———give greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural, physical, and computing sciences (see H. Res. 98), H1178 (see H. Res. 98), H1197 [17FE]

Taxation: exempt certain emergency medical devices from the excise tax on medical devices (see H.R. 1310), H2265 [1AP]

———repeal excise tax on medical devices (see S. 262), S543 [3FE] (see H.R. 436), H469 [25JA] (see H.R. 488), H508 [26JA] (see H.R. 734), H1038 (see H.R. 734), H1069 [16FE]

Tobacco products: clarify FDA jurisdiction over certain tobacco products and protect jobs and small businesses involved in the sale, manufacturing, and distribution of cigars (see S. 1461), S5191 [1AU] (see H.R. 1639), H2912 [15AP]

Women: protect breastfeeding, provide performance standards for breast pumps, provide tax incentives to employers to encourage breastfeeding, and provide reasonable break time for nursing mothers (see S. 1463), S5191 [1AU] (see H.R. 2758), H5884 [1AU]

Cloture motions

Agriculture, rural development, FDA, and related agencies programs: making appropriations (H.R. 2112), S6758 [19OC], S6847 [20OC]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), motion to proceed, S1247 [4MR]

Conference reports

Consolidated and Further Continuing Appropriations Act (H.R. 2112), H7433-H7576 [14NO]

Letters

Encourage FDA approval of artificial pancreas technologies: Representative Burton, E2139 [30NO]

FDA use of hard science in developing regulations: Anne L. Miller, Montana Pork Producers Council, H4237 [15JN]

———Bill Donald, National Cattlemen's Beef Association, H4237 [15JN]

———Doug Wolf, National Pork Producers Council, H4237 [15JN]

Generating Antibiotic Incentives Now (GAIN) Act: B. Keith English, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, S7029 [2NO]

———Meri Armour, Le Bonheur Children's Hospital, S7029 [2NO]

———several East Tennessee State University administrators and faculty, S7029 [2NO]

———William E. Evans, St. Jude Children's Research Hospital, S7028 [2NO]

Lists

Federal aid programs for low-income people, H2212 [31MR]

Motions

Agriculture, rural development, FDA, and related agencies programs: making appropriations (H.R. 2112), S6717, S6740 [19OC], H4312 [16JN], H7273 [3NO]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), S1247 [4MR], H1355 [18FE]

Remarks in House

Abortion: prohibit funding for distribution of mifepristone (RU-486) through telemedicine, H4268, H4269 [15JN], H4319 [16JN]

Agriculture, rural development, FDA, and related agencies programs: across-the-board funding reduction, H4289, H4290 [16JN]

———conservation programs funding, H4205 [15JN], E1209 [24JN]

———exempt from certain requirements on the procurement and acquisition of alternative fuels, H4292, H4293 [16JN]

———making appropriations (H.R. 2112), H4079, H4081, H4094, H4095, H4108-H4183 [14JN], H4194, H4202-H4274 [15JN], H4283-H4314, H4319-H4322 [16JN], E1098, E1106, E1107, E1109 [15JN], E1113, E1115, E1118, E1121, E1123, E1128 [16JN], E1147 [21JN], E1154, E1159, E1162 [22JN], E1200, E1209 [24JN], E1260 [7JY]

———making appropriations (H.R. 2112), conference report, H7629 [16NO], H7746-H7782 [17NO], E2080 [17NO], E2100, E2103, E2108 [18NO], E2138 [30NO]

———making appropriations (H.R. 2112), consideration (H. Res. 300), H4096-H4104 [14JN]

———making appropriations (H.R. 2112), consideration of conference report (H. Res. 467), H7733-H7737 [17NO]

———making appropriations (H.R. 2112), motion to instruct conferees, H7273-H7279 [3NO]

———making appropriations (H.R. 2112), motion to recommit, H4312, H4313 [16JN]

———prohibit funding to lease or purchase new light duty vehicles except in accordance with Presidential memorandum on Federal fleet performance, H4268 [15JN]

Appropriations: direct CBO and BLS to conduct a joint study on effect of full-year continuing appropriations legislation on job levels and report findings in the Employment Situation Report, H1243, H1244 [18FE]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), H727, H746, H750-H754 [14FE], H801, H803, H804, H817-H913 [15FE], H937, H941, H942, H944, H948, H949, H950, H951, H955, H957-H1036, H1043-H1068 [16FE], H1074, H1080-H1175, H1181-H1189 [17FE], H1201, H1202-H1249, H1255-H1357 [18FE], H1366, H1378-H1382 [28FE], H1395, H1398, H1404, H1405, H1406-H1415, H1417-H1419, H1425, H1429, H1442-H1445 [1MR], H1460, H1463, H1464, H1485, H1502, H1503, H1517 [2MR], H1527, H1528, H1554-H1557, H1561 [3MR], H1627, H1628, H1629, H1643-H1649 [9MR], H1672, H1673, H1676, H1699, H1712 [10MR], H1751-H1761 [11MR], H1773 [14MR], H1805-H1810, H1821, H1822, H1828, H1836 [15MR], H1849, H1850, H1859, H1901 [16MR], H1980 [17MR], H2004, H2007 [29MR], H2046, H2048, H2049, H2050, H2063, H2065-H2067, H2092 [30MR], H2113, H2118, H2119 [31MR], H2217, H2218, H2225, H2228, H2230, H2248 [1AP], H2272 [4AP], H2299, H2301, H2302, H2314 [5AP], H2331, H2336, H2392, H2395, H2401 [6AP], H2414, H2453 [7AP], H2541, H2544, H2547, H2549, H2550 [8AP], H2598 [12AP], H2739, H2743, H2789 [14AP], H2903 [15AP], H5739 [29JY], H5860 [1AU], H6677 [11OC], E222 [14FE], E238, E239, E240, E241, E242, E243, E245, E247, E248, E249, E250, E251 [16FE], E253, E254, E255, E257, E258, E259 [17FE], E261, E262, E269, E270, E271, E272, E273, E275, E276, E277, E278, E279, E280, E281, E282, E283, E284, E286, E287, E288, E289, E290, E291, E292, E293, E295, E296, E297, E298, E299, E300, E301, E302, E303, E305, E308, E310, E312, E317, E318, E319 [18FE], E321, E322, E324, E333, E336 [28FE], E388, E389 [1MR], E396 [2MR], E413, E414, E415, E416 [3MR], E500 [16MR]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), motion to recommit, H1355 [18FE]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), unanimous-consent agreement, H1174, H1175 [17FE]

Center for Devices and Radiological Health: funding, H4218 [15JN]

Center for Food Safety and Applied Nutrition: funding, H4164 [14JN]

Center for Tobacco Products: funding, H4218 [15JN]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (H.R. 2659), E1411 [26JY]

Crime: decriminalization of marijuana, H4373 [22JN], H4468 [23JN]

Dept. of Agriculture: funding, E275 [18FE]

Dept. of HHS: reauthorize certain programs to protect against pandemics and attacks from chemical, biological, radiological, and nuclear weapons (H.R. 2405), H8153-H8159 [6DE], E2205 [7DE]

Diseases: encourage research on artificial pancreas technology, E1239 [6JY]

———establish a comprehensive interagency response to reduce lung cancer mortality in a timely manner (H.R. 1394), H4739 [7JY]

———help prevent occurrence of cancer resulting from the use of ultraviolet tanning lamps by imposing more stringent controls on the use of such devices (H.R. 1676), E778 [2MY]

———increase support and research to combat juvenile diabetes, H5502 [26JY]

———new guidelines for development of artificial pancreas systems to help cure type 1 juvenile diabetes, H8745 [13DE]

———reduce disparities and improve access to diagnosis and treatment of prostate cancer for underserved populations and men with a family history of prostate cancer (H.R. 2159), E1082 [14JN]

Economy: impact of Government regulations, H633-H673 [10FE], H687-H714 [11FE], H2024-H2029 [29MR]

Fish and fishing: prohibit funding for approval of genetically-engineered salmon, H4240 [15JN]

Food: food safety activities funding, H4253-H4256 [15JN]

———recall of grapes and tomatoes for salmonella contamination, H8087 [2DE]

Food Day: observance, E1917 [24OC]

Funding, H824 [15FE], E1123 [16JN]

Government regulations: ensure regulations do not limit access to dietary supplements, H8266 [8DE]

———exempt any rulemaking to carry out the FDA Food Safety Modernization Act from requirement of complete analysis of potential impacts of rules on small entities, H8049, H8050 [1DE]

———improve efficiency and transparency of medical device approval process, H637 [10FE]

———require certain agencies to submit a cost-benefit analysis to Congress before implementing proposed regulations with significant economic impact (H.R. 2175), E1091 [14JN]

———require use of hard science in developing regulations, H4236-H4238 [15JN]

Health: allow use of regenerative medicine for treatment and cure of chronic diseases, H378 [20JA]

Interagency Working Group on Food Marketed to Children: impact of proposed guidelines on food and beverage industries, H7638, H7640 [16NO], E2066 [16NO]

Patents: clarify calculation of filing period deadline for patent term extension applications, H4432, H4433 [22JN], H4489, H4490 [23JN]

Pharmaceuticals: clarification of order approving the drug Makena for women at risk for preterm birth but denying Makena market exclusivity, H2050 [30MR]

Research: encourage approval of artificial pancreas technologies, E1939, E1946 [26OC], E2093 [18NO], E2139 [30NO]

———encourage approval of artificial pancreas technology, H6358 [22SE], E1785 [6OC]

Science: give greatest weight in making critical policy decisions to readily available hard science data, including evidence from the natural, physical, and computing sciences (H. Res. 98), H4238 [15JN]

Taxation: repeal excise tax on medical devices (H.R. 436), H5971 [8SE], H7124 [26OC], H7249-H7253 [2NO]

Tobacco Products Scientific Advisory Committee: address financial and ethical conflicts of interest among members, E542 [29MR]

Remarks in Senate

Agriculture, rural development, FDA, and related agencies programs: across-the-board funding reduction, S6740 [19OC], S6936 [1NO]

———making appropriations (H.R. 2112), S6573, S6575-S6581, S6587-S6590 [17OC], S6623, S6633-S6653 [18OC], S6704, S6706, S6708-S6713, S6716, S6717, S6724-S6756, S6786 [19OC], S6791-S6815, S6817-S6819, S6829, S6833-S6853 [20OC], S6899-S6901, S6911, S6912 [31OC], S6932-S6981, S6983, S6986 [1NO], S7061 [2NO], S7100 [3NO]

———making appropriations (H.R. 2112), conference report, S7433 [15NO], S7677, S7678-S7684 [17NO], S7825, S7826 [18NO]

———making appropriations (H.R. 2112), conference report—unanimous-consent agreement, S7673 [17NO]

———making appropriations (H.R. 2112), motion to recommit, S6740 [19OC], S6936 [1NO]

———making appropriations (H.R. 2112), unanimous-consent agreement, S6561 [13OC], S6657 [18OC], S6758 [19OC], S6838, S6847 [20OC]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), S822 [17FE], S1022 [28FE], S1023-S1028 [1MR], S1087 [2MR], S1179, S1185-S1193, S1204, S1206-S1208 [3MR], S1245-S1247 [4MR], S1415-S1419, S1421-S1495 [9MR], S1515, S1533, S1544 [10MR], S1591 [14MR], S1614, S1650 [15MR], S1728 [16MR], S1908 [29MR], S1950 [30MR], S2005, S2014, S2035-S2037 [31MR], S2114 [5AP], S2157, S2181, S2186 [6AP], S2236, S2254 [7AP], S2293, S2304 [8AP], S2438, S2439 [13AP], S3717 [13JN]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), motion to proceed, S1247-S1250 [4MR], S1309-S1313, S1315-S1318, S1320 [7MR], S1336-S1348, S1350-S1360, S1394-S1398 [8MR]

———making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), unanimous-consent request, S1247 [4MR]

Dept. of HHS: reauthorize certain programs to protect against pandemics and attacks from chemical, biological, radiological, and nuclear weapons (S. 1855), S7382-S7384 [10NO]

Dietary supplements: improve safety by requiring manufacturers to register supplement products with the FDA and amending labeling requirements (S. 1310), S4294 [30JN]

Diseases: establish a comprehensive interagency response to reduce lung cancer mortality in a timely manner (S. 752), S2208 [6AP]

Drugs: improve capacity to prevent drug shortages (S. 296), S6901 [31OC]

———increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (S. 507), S1408 [8MR]

———prohibit funding to prevent individuals from importing prescription drugs from Canada for personal use, S6650 [18OC], S6730, S6749 [19OC], S6794, S6797, S6801 [20OC]

Food Day: political agenda of sponsoring organizations, S6762 [19OC]

Government regulations: finalize proposed rule on sunscreen product labeling (S. 1064), S3343 [25MY]

———improve efficiency and transparency of medical device approval process, S3800 [15JN]

Hereditary Angioedema Awareness Day: observance (S. Res. 286), S6226 [5OC]

Patent and Trademark Office: prohibit funding to implement clarification of calculation of filing period deadline for patent term extension applications, S6755 [19OC], S6814, S6815 [20OC]

Patents: clarify calculation of filing period deadline for patent term extension applications, S3713 [13JN], S5403-S5407, S5420, S5425, S5434, S5435, S5436, S5442 [8SE]

Pharmaceuticals: allow importation of prescription drugs (S. 319), S644 [10FE]

———cost regulation of drug hormone, progesterone, to prevent premature births, S2800 [9MY]

———ensure valid generic drugs may enter the market (S. 1882), S7616 [16NO]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (S. 27), S143 [25JA]

Pharmacies: improve the safety of Internet pharmacies (S. 2002), S8684 [15DE]

Research: provide incentives for the development of qualified infectious disease products (H.R. 2182), S7028-S7030 [2NO]

Science: establish a nanotechnology regulatory science program (S. 1662), S6332 [6OC]

Taxation: repeal excise tax on medical devices (S. 262), S545 [3FE]

Reports filed

Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Committee on Appropriations (House) (H.R. 2112) (H. Rept. 112-101), H4034 [3JN]

———Committee on Appropriations (Senate) (H.R. 2112) (S. Rept. 112-73), S5386 [7SE]

Consideration of Conference Report on H.R. 2112, Consolidated and Further Continuing Appropriations Act: Committee on Rules (House) (H. Res. 467) (H. Rept. 112-290), H7713 [16NO]

Consideration of H.R. 1, Dept. of Defense and Other Departments and Agencies Appropriations, Unobligated Stimulus Funds Rescission, and Discretionary Spending Reduction: Committee on Rules (House) (H. Res. 92) (H. Rept. 112-13), H773 [14FE]

Consideration of H.R. 2112, Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Committee on Rules (House) (H. Res. 300) (H. Rept. 112-103), H4074 [13JN]

Consolidated and Further Continuing Appropriations Act: Committee of Conference (H.R. 2112) (H. Rept. 112-284), H7577 [14NO]

Dept. of HHS Programs To Protect Against Pandemics and Attacks From Chemical, Biological, Radiological, and Nuclear Weapons Reauthorization: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1855), S8733 [16DE]

Dept. of HHS Reauthorization of Programs To Protect Against Pandemics and Attacks From Chemical, Biological, Radiological, and Nuclear Weapons: Committee on Energy and Commerce (House) (H.R. 2405) (H. Rept. 112-286), H7712 [16NO]

Preserve Access to Affordable Generics Act: Committee on the Judiciary (Senate) (S. 27), S4845 [22JY]

Rulings of the Chair

Agriculture, rural development, FDA, and related agencies programs: making appropriations (H.R. 2112), H4166, H4178 [14JN], H4238, H4239 [15JN], H4289 [16JN]

Appropriations: making for Dept. of Defense and other Federal departments and agencies, rescind unobligated stimulus funds, and reduce discretionary spending (H.R. 1), H879, H883, H890, H897 [15FE], H970, H984, H988, H991, H994, H1008, H1025, H1028, H1029, H1033, H1034, H1044, H1064 [16FE], H1103, H1111, H1115 [17FE], H1203, H1215, H1222, H1232, H1244, H1271, H1282, H1288 [18FE]

Statements

Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Executive Office of the President, H4262 [15JN]

Cuts to International Food Aid Programs in H.R. 2112, Agriculture, Rural Development, FDA, and Related Agencies Programs Appropriations: Representative McGovern, H4104 [14JN]

Tables

Agriculture, rural development, FDA, and related agencies programs appropriations (H.R. 2112), S6754 [19OC], H4112-H4121 [14JN]

Consolidated and Further Continuing Appropriations Act (H.R. 2112): conference report, H7747-H7769 [17NO]

Texts of

H. Res. 92, consideration of H.R. 1, Dept. of Defense and other Federal departments and agencies appropriations, unobligated stimulus funds rescission, and discretionary spending reduction, H804 [15FE]

H. Res. 300, consideration of H.R. 2112, agriculture, rural development, FDA, and related agencies programs appropriations, H4096 [14JN]

H. Res. 467, consideration of conference report on H.R. 2112, Consolidated and Further Continuing Appropriations Act, H7733 [17NO]

H.R. 2112, agriculture, rural development, FDA, and related agencies programs appropriations, S6937-S6979 [1NO]

H.R. 2405, Dept. of HHS programs to protect against pandemics and attacks from chemical, biological, radiological, and nuclear weapons reauthorization, H8153-H8157 [6DE]

S. 27, Preserve Access to Affordable Generics Act, S144-S146 [25JA]

S. 752, Lung Cancer Mortality Reduction Act, S2209 [6AP]

S. 1064, Sunscreen Labeling Protection (SUN) Act, S3344 [25MY]

S. 1310, Dietary Supplement Labeling Act, S4294 [30JN]

S. 1662, Nanotechnology Regulatory Science Act, S6333 [6OC]

S. 1882, Fair and Immediate Release of Generic Drugs (FAIR Generics) Act, S7616 [16NO]

S. 2002, Online Pharmacy Safety Act, S8685-S8687 [15DE]

S. Res. 286, Hereditary Angioedema Awareness Day, S6225 [5OC]